Beruflich Dokumente
Kultur Dokumente
of Antimicrobial
Therapy
Poor perfusion
Pay attention to specific cond related to PK
Pay attention to specific cond related to PK
III. Safety and Cost-benefit
Safety
IV. Bacteriostatic vs.
Bactericidal AM
V. Spectrum of AM
VI. Combination of AM
Select if possible only single AM
It prevents:
Superinfections
emerge of drug resistance
Minimize toxicity
the cost
Cell entry
Attachment Soluble receptor decoy, antireceptor
Penetration antibodies
Uncoating Ion chanel blockers, capsid stabilzer
Release of viral genome
Transcription of viral genome Inhibitor of polimerase, reverse
trans
Transcription of viral messenger RNA criptase, helicase, primase,
integrase
Replication of viral genome
Translation of viral proteins Interferon, antisense oligonucleoti-
Regulatory proteins (early) Inhibitors of regolatory proteins
Structural proteins (late)
Posttranslational modifications
Proteolytic cleavage Protease inhibitor
Myristoylation, glycosylation
Assembly of virion components Interferon
Release Neuraminidase inhibitor, antiviral
Budding, cell lysis antibody, cytotoxic lymphocytes
ANTIFUNGAL DRUGS
27
Anti
fungal
Endo- and
ectoparas
ites:
therapeut
ic agents
Resistance to AM
If with max dose of AM (tolerated by the host)
Resistance to AM
Can be spread
Resistance to AB:
mechanism?
Multidrug Resistance
(MDR)
Resistance to commonly used AB
MDR- TB (resistant to >2 anti-TB drugs)
Some strains of Staph. &enterococc. (resistant to
most all AB)